7,111,969-$1.715.45%$29.68[Oracle][ORCL]• Vol: 10,510,788-$6.123.91%$150.43[Copart][CPRT]• Vol: 10,973,155-$1.473.90%$36.18[Newmont][NEM]• Vol: 5,055,402-$4.533.61%$120.87 Hims & Hers $1.2 Billion Global Leap: Can Eucalyptus Cure its GLP-1 Ills? - 24/7 Wall St.[S&P 5006,905.00 +0.65%][Dow Jones49,505.00 +0.28%][Nasdaq 10025,049.60 +1.07%][Russell 20002,662.73 +0.01%][FTSE 10010,708.60 +0.26%][Nikkei 22557,158.00 +0.12%][Stock Market Live February 20, 2026: S&P 500 (SPY) Sinks on US GDP Numbers][Investing]# ...

Core Insights - iRhythm Holdings, Inc. reported strong financial results for Q4 and full year 2025, marking a transformational year with significant revenue growth and positive net income for the first time in its history [4][10]. Financial Highlights Fourth Quarter 2025 - Revenue increased by 27.1% to $208.9 million compared to $164.3 million in Q4 2024, driven by higher demand for Zio Services [5][8]. - Gross profit rose to $148.1 million, up from $115.1 million in Q4 2024, with a gross margin of 70.9%, an improvement from 70.0% [6][8]. - Net income for Q4 2025 was $5.6 million, a significant improvement from a net loss of $1.3 million in Q4 2024 [9][8]. - Adjusted EBITDA was $34.3 million, with an adjusted EBITDA margin of 16.4%, reflecting a $15.0 million increase compared to Q4 2024 [8]. Full Year 2025 - Total revenue for 2025 reached $747.1 million, a 26.2% increase from $591.8 million in 2024 [10][11]. - Gross profit for the year was $527.3 million, up from $407.5 million in 2024, with a gross margin of 70.6%, improving from 68.9% [11]. - The net loss for 2025 was $44.6 million, a $68.7 million improvement compared to a net loss of $113.3 million in 2024 [12][10]. - Free cash flow for 2025 was $34.5 million, marking the first year of positive free cash flow in the company's history [8]. Operational Highlights - The company emphasized the growing demand for Zio across various healthcare sectors, highlighting its ability to provide proactive, data-driven arrhythmia detection [4]. - iRhythm plans to scale its platform globally, advance its product roadmap, and enhance its predictive AI capabilities while maintaining financial discipline [4]. 2026 Guidance - For 2026, iRhythm expects revenue between $870 million and $880 million, with an adjusted EBITDA margin of 11.5% to 12.5%, indicating continued growth and operational efficiency [13].

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Omada for Cholesterol closes a critical gap in cardiovascular care, delivering between-visit support for the many adults whose LDL remains uncontrolled under usual care¹SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit healthcare provider, today announced the expansion of its integrated platform to include dedicated cholesterol management alongside weight, glucose, blood pressure, and GLP-1 support. Up to 70% of adults with obesity have high chole ...

With strong underlying market demand, European distributor and expert physician customer purchase orders are being received by the Company as its 2026 revenue guidance range increases to $1.5 million - $3 million BERKELEY, Calif, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, announces it has received ...

Hims & Hers Health has agreed to acquire digital health company Eucalyptus in a deal valued at $1.15 billion in an effort to expand its geographic reach. ...

Core Viewpoint - Hims & Hers Health is acquiring Australian digital health company Eucalyptus for a deal valued at up to $1.15 billion, aiming to expand its personalized telehealth services [1] Group 1: Acquisition Details - The acquisition is valued at up to $1.15 billion, indicating a significant investment in expanding digital health capabilities [1] - Eucalyptus is recognized for its innovative approach in the digital health sector, which aligns with Hims & Hers Health's strategy to enhance its service offerings [1] Group 2: Strategic Intent - The acquisition reflects Hims & Hers Health's commitment to broadening its telehealth platform and enhancing personalized healthcare solutions [1] - This move is part of a larger trend in the healthcare industry where companies are increasingly focusing on digital health solutions to meet consumer demands [1]

CIMG Inc. Reports Fiscal Year 2025 Financial Results [Accessibility Statement] Skip NavigationHONG KONG, Feb. 18, 2026 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technologies and marketing networks to enhance its business partners' sales growth and commercial value, today reports its financial results for the fiscal year ended September 30, 2025, as reported in the Company's audited consolidated fin ...

Hydreight Technologies ( NURS:CA ) ( HYDTF ) is a story of high growth through a mix of segments with concepts already proven in other industries, but focused on digital health, such as the "Uber of nurses" andMy name is María Fernanda and I'm currently studying an MBA. My inspiration investors are Warren Buffett, Peter Lynch and Terry Smith, so I look for quality companies at a reasonable valuation. I believe that, in the long term, fundamentals are what drive the share price, so I look to predict what a b ...

Core Insights - The healthcare industry is experiencing a significant shift towards technology-enabled care, driven by the need for operational efficiency and cost reduction. Payers and health systems are adopting unified platforms to enhance patient engagement and streamline workflows [1][2][3] Industry Trends - The Medicare population is aging, pharmacy costs are rising, and overall healthcare expenses are increasing, particularly in behavioral health and GLP-1 usage. Clinician shortages and evaporating subsidies are putting pressure on payer margins, making technology-enabled care essential [2] - The integration of AI in healthcare is rapidly evolving, with a focus on improving clinical programs and patient outcomes. The ability to manage multiple AI solutions effectively is becoming a critical challenge for healthcare providers [5][26] Company Strategy - American Well Corporation has undergone a transformation to focus exclusively on its technology platform, aiming for cash flow breakeven by Q4 2026. The company is consolidating its offerings to enhance operational efficiency and improve revenue quality [3][20] - The company has divested non-core activities and streamlined its operations, resulting in a significant reduction in costs and improved subscription revenue, which now constitutes 53% of total revenue, up from 45% in 2024 [11][12] Financial Performance - In 2025, American Well Corporation reported total revenue of $249.3 million, with a notable reduction in net loss and adjusted EBITDA losses by approximately $100 million each. The fourth quarter saw total revenue of $55.3 million, reflecting a 22.1% year-over-year decline, primarily due to contract changes and business reprioritization [11][12][13] - The company expects revenue for 2026 to be between $195 million and $205 million, with adjusted EBITDA losses projected between $24 million and $18 million. The guidance reflects expectations of continued subscription stability and operational efficiencies [17][18] Market Position - American Well Corporation's platform is positioned as a critical utility for healthcare providers, enabling them to integrate various clinical programs and maintain network adequacy, especially in behavioral health services [6][7] - The company has secured over 15 payer contract renewals, strengthening its recurring revenue base and positioning for future growth. The focus on high-quality, sticky revenue is expected to drive same-store growth and enhance market penetration [9][45]